Summary
Boston Scientific Corporation (BSX) filed an 8-K on October 28, 2015, primarily to furnish a press release detailing its third quarter financial results for the period ending September 30, 2015. This filing provides investors with key performance metrics and insights into the company's operational and financial standing during the quarter. The information is presented through an attached press release, which is a standard method for publicly traded companies to disseminate timely financial information to the market. Investors should review the furnished press release for specific financial details, trends, and management commentary on the company's performance and outlook. While the 8-K itself is concise, it serves as a gateway to the more detailed financial information presented in the accompanying press release. Investors are advised to examine the press release for specifics on revenue, earnings per share (EPS), segment performance, and any forward-looking guidance. The furnishing of this information under Item 2.02 signifies its release to the public and is crucial for understanding the company's recent financial health and strategic direction.
Key Highlights
- 1The 8-K filing announces Boston Scientific's financial results for the third quarter ended September 30, 2015.
- 2The primary content of the filing is a press release (Exhibit 99.1) detailing these financial results.
- 3The filing was made on October 28, 2015, with an event date of October 27, 2015.
- 4This report serves to officially inform the market of the company's Q3 2015 performance.
- 5Information furnished under Item 2.02 is not considered 'filed' for Section 18 liability purposes, but is important for investor awareness.
- 6Investors are directed to the attached press release for specific financial figures and commentary.